Deuruxolitinib
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Patient preferences for treatment characteristics of Janus kinase inhibitors for alopecia areata: a discrete choice experiment.
Journal: The Journal of dermatological treatment
Published: May 15, 2026
Therapeutic update on alopecia areata: a critical review of standard and emerging targeted therapies.
Journal: Inflammopharmacology
Published: March 25, 2026
Exploring novel management options for alopecia areata.
Journal: The American journal of managed care
Published: March 04, 2026
Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata.
Journal: Journal of drugs in dermatology : JDD
Published: March 04, 2026
Large-scale meta-analysis of infection risk with JAK-STAT inhibitors in 29,000 patients.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: January 19, 2026
Deuruxolitinib (Leqselvi) for severe alopecia areata.
Journal: The Medical letter on drugs and therapeutics
Published: October 21, 2025
Treatment of alopecia areata with JAK inhibitors: a review of the literature.
Journal: Acta dermatovenerologica Alpina, Pannonica, et Adriatica
Published: August 25, 2025
Comparative Efficacy of Janus Kinase Inhibitors Indicated for Severe Alopecia Areata: A Bayesian Network Meta-Analysis and Matching-Adjusted Indirect Comparison.
Journal: The Journal of dermatology
Published: August 04, 2025
Last Updated: 06/30/2026